Advertisement
The objective is to advertise the opening of this new regional service.About this Event
Event Objectives :
- Introduce the service.
- Explain the key benefits and intended impact.
- Showcase the launch through presentations, demonstrations and case studies.
- Provide opportunities for questions, discussion and networking.
- Confirm next steps, support and points of contact.
Allthough there is no registration fee, please could we ask you to register for the event so that the appropriate arrangements can be made for the day - thank you
Agenda
🕑: 10:00 AM - 10:20 AM
Registration
🕑: 10:20 AM - 10:30 AM
Welcome, introductions and event overview
Host: Professor Rob Cooper
🕑: 10:30 AM - 10:45 AM
History and background (the case for a service), and later
"Novel therapies in AL Amyloidosis: daratumumab and beyond"
Host: Dr. Stephen Hawkins
🕑: 10:45 AM - 11:05 AM
Midland's experience
Host: Dr. Will Moody
🕑: 11:05 AM - 11:30 AM
Diagnostic pathway for ATTR
Host: Professor Andrew Crean
🕑: 11:30 AM - 12:15 PM
Evolving Landscape of Novel Therapies for Transthyretin Cardiac Amyloidosis
Host: Professor Julian Gilmore
🕑: 12:15 PM - 01:15 PM
Lunch, Networking and Exhibitions
🕑: 01:15 PM - 02:15 PM
Demo of MDT
Host: Professor Rob Cooper
🕑: 02:15 PM - 02:35 PM
Renal talk - Title TBC
Host: Dr. Shahed Ahmed
🕑: 02:35 PM - 03:05 PM
Novel Therapies in AL Amyloidosis: Daratumumab and Beyond
Host: Dr. Stephen Hawkins
🕑: 03:05 PM - 03:25 PM
Afternoon Tea, Networking and Exhibitions
🕑: 03:25 PM - 03:50 PM
Treatment of Neuropathy
Host: Dr. James Holt
🕑: 03:50 PM - 04:10 PM
Patient Story - TBC
🕑: 04:10 PM - 04:20 PM
Amyloidosis UK - TBC
🕑: 04:20 PM - 04:45 PM
Service logistics/how to refer/engage
Host: Dr. Gillian Brearton
🕑: 04:45 PM - 05:00 PM
Conclusions and closing remarks
Host: Professor Rob Cooper
🕑: 05:00 PM
Session Close
Advertisement
Event venue & nearby stays
INNSIDE by Meliá, 43, Old Hall Street,, Liverpool, United Kingdom
Tickets
GBP 0.00